vs

Side-by-side financial comparison of CME Group (CME) and G III APPAREL GROUP LTD (GIII). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $988.6M, roughly 1.9× G III APPAREL GROUP LTD). G III APPAREL GROUP LTD runs the higher net margin — 8.2% vs 0.1%, a 8.1% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -9.0%). Over the past eight quarters, G III APPAREL GROUP LTD's revenue compounded faster (13.7% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

G III Apparel Group is a global fashion company that designs, sources, manufactures, markets and distributes apparel, footwear, and accessories under a range of owned and licensed well-known brands. It serves department stores, specialty retailers, and e-commerce platforms across North America, Europe, and other key global markets, catering to casual, sportswear, and premium fashion consumer segments.

CME vs GIII — Head-to-Head

Bigger by revenue
CME
CME
1.9× larger
CME
$1.9B
$988.6M
GIII
Growing faster (revenue YoY)
CME
CME
+23.5% gap
CME
14.5%
-9.0%
GIII
Higher net margin
GIII
GIII
8.1% more per $
GIII
8.2%
0.1%
CME
Faster 2-yr revenue CAGR
GIII
GIII
Annualised
GIII
13.7%
10.8%
CME

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CME
CME
GIII
GIII
Revenue
$1.9B
$988.6M
Net Profit
$1.2M
$80.6M
Gross Margin
38.6%
Operating Margin
0.1%
11.4%
Net Margin
0.1%
8.2%
Revenue YoY
14.5%
-9.0%
Net Profit YoY
20.7%
-29.8%
EPS (diluted)
$1.84

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
GIII
GIII
Q1 26
$1.9B
Q4 25
$1.6B
$988.6M
Q3 25
$1.5B
$613.3M
Q2 25
$1.7B
$583.6M
Q1 25
$1.6B
$839.5M
Q4 24
$1.5B
$1.1B
Q3 24
$1.6B
$644.8M
Q2 24
$1.5B
$609.7M
Net Profit
CME
CME
GIII
GIII
Q1 26
$1.2M
Q4 25
$1.2B
$80.6M
Q3 25
$908.0M
$10.9M
Q2 25
$1.0B
$7.8M
Q1 25
$956.2M
$48.8M
Q4 24
$874.6M
$114.8M
Q3 24
$912.8M
$24.2M
Q2 24
$883.2M
$5.8M
Gross Margin
CME
CME
GIII
GIII
Q1 26
Q4 25
38.6%
Q3 25
40.8%
Q2 25
42.2%
Q1 25
39.5%
Q4 24
39.8%
Q3 24
42.8%
Q2 24
42.5%
Operating Margin
CME
CME
GIII
GIII
Q1 26
0.1%
Q4 25
61.8%
11.4%
Q3 25
63.3%
2.7%
Q2 25
66.7%
1.5%
Q1 25
67.5%
8.5%
Q4 24
62.1%
15.3%
Q3 24
64.6%
6.4%
Q2 24
65.3%
2.2%
Net Margin
CME
CME
GIII
GIII
Q1 26
0.1%
Q4 25
71.7%
8.2%
Q3 25
59.1%
1.8%
Q2 25
60.6%
1.3%
Q1 25
58.2%
5.8%
Q4 24
57.3%
10.6%
Q3 24
57.6%
3.8%
Q2 24
57.6%
1.0%
EPS (diluted)
CME
CME
GIII
GIII
Q1 26
Q4 25
$3.24
$1.84
Q3 25
$2.49
$0.25
Q2 25
$2.81
$0.17
Q1 25
$2.62
$1.00
Q4 24
$2.40
$2.55
Q3 24
$2.50
$0.53
Q2 24
$2.42
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
GIII
GIII
Cash + ST InvestmentsLiquidity on hand
$2.4B
$184.1M
Total DebtLower is stronger
$3.4B
$6.5M
Stockholders' EquityBook value
$1.8B
Total Assets
$202.0B
$2.8B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
GIII
GIII
Q1 26
$2.4B
Q4 25
$4.5B
$184.1M
Q3 25
$2.6B
$301.8M
Q2 25
$2.1B
$257.8M
Q1 25
$1.5B
$181.4M
Q4 24
$3.0B
$104.7M
Q3 24
$2.4B
$414.8M
Q2 24
$1.9B
$508.4M
Total Debt
CME
CME
GIII
GIII
Q1 26
$3.4B
Q4 25
$6.5M
Q3 25
$6.9M
Q2 25
$6.8M
Q1 25
$3.0M
Q4 24
$213.9M
Q3 24
$402.5M
Q2 24
$402.7M
Stockholders' Equity
CME
CME
GIII
GIII
Q1 26
Q4 25
$28.7B
$1.8B
Q3 25
$28.2B
$1.7B
Q2 25
$27.7B
$1.7B
Q1 25
$27.0B
$1.7B
Q4 24
$26.5B
$1.6B
Q3 24
$28.2B
$1.5B
Q2 24
$27.6B
$1.5B
Total Assets
CME
CME
GIII
GIII
Q1 26
$202.0B
Q4 25
$198.4B
$2.8B
Q3 25
$187.1B
$2.7B
Q2 25
$179.9B
$2.4B
Q1 25
$157.8B
$2.5B
Q4 24
$137.4B
$2.8B
Q3 24
$137.8B
$2.7B
Q2 24
$123.4B
$2.6B
Debt / Equity
CME
CME
GIII
GIII
Q1 26
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.13×
Q3 24
0.27×
Q2 24
0.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
GIII
GIII
Operating Cash FlowLast quarter
$-97.3M
Free Cash FlowOCF − Capex
$-106.4M
FCF MarginFCF / Revenue
-10.8%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
-1.21×
TTM Free Cash FlowTrailing 4 quarters
$367.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
GIII
GIII
Q1 26
Q4 25
$1.1B
$-97.3M
Q3 25
$968.1M
$75.1M
Q2 25
$1.1B
$93.8M
Q1 25
$1.1B
$333.4M
Q4 24
$1.0B
$-111.8M
Q3 24
$1.0B
$49.3M
Q2 24
$776.9M
$45.5M
Free Cash Flow
CME
CME
GIII
GIII
Q1 26
Q4 25
$1.1B
$-106.4M
Q3 25
$949.7M
$64.7M
Q2 25
$1.0B
$85.7M
Q1 25
$1.1B
$323.7M
Q4 24
$991.7M
$-120.3M
Q3 24
$973.2M
$38.8M
Q2 24
$758.7M
$32.8M
FCF Margin
CME
CME
GIII
GIII
Q1 26
Q4 25
66.8%
-10.8%
Q3 25
61.8%
10.6%
Q2 25
61.5%
14.7%
Q1 25
67.1%
38.6%
Q4 24
65.0%
-11.1%
Q3 24
61.4%
6.0%
Q2 24
49.5%
5.4%
Capex Intensity
CME
CME
GIII
GIII
Q1 26
Q4 25
2.0%
0.9%
Q3 25
1.2%
1.7%
Q2 25
1.1%
1.4%
Q1 25
0.9%
1.2%
Q4 24
1.7%
0.8%
Q3 24
1.9%
1.6%
Q2 24
1.2%
2.1%
Cash Conversion
CME
CME
GIII
GIII
Q1 26
Q4 25
0.96×
-1.21×
Q3 25
1.07×
6.86×
Q2 25
1.03×
12.09×
Q1 25
1.17×
6.83×
Q4 24
1.16×
-0.97×
Q3 24
1.10×
2.04×
Q2 24
0.88×
7.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

GIII
GIII

Proprietary Brands$498.1M50%
Licensed Brands$479.2M48%
Retail Segment$45.7M5%

Related Comparisons